Zyloware to distribute Inspecs USA NASCAR collection

Article

Zyloware Eyewear will handle distribution of Inspecs USA NASCAR Optical collection in the United States, Canada, and Latin America.

Port Chester, NY – Zyloware Eyewear will handle distribution of Inspecs USA NASCAR Optical collection in the United States, Canada, and Latin America. 

NASCAR Optical is targeted toward men ages 20s – 40s. Drawing inspiration from racecars, the NASCAR Optical collection is comprised of eight new styles (in two colors each) reflecting the history and integrity of the NASCAR brand. 

The collection is comprised of four full rim and four semi-rimless styles featuring metal fronts and anti-slip double injection TR90 temples, providing a minimalist, sporty look with the comfort and flexibility of lightweight engineering, according to the company. Carbon fiber trim inserts on the temple as well as a laser engraved logo on the outside temple provide sleek and modern detailing and instant brand recognition, according to Zyloware.

With more than 75 million fans, NASCAR is the number one spectator sport in the country.  NASCAR boasts the most brand loyal fans in all sport and it is estimated that 1 in 3 US adults are NASCAR fans. According to Zyloware, 89% of these fans equate the NASCAR logo with a quality product.

Inspecs USA is the American arm of British-based eyewear manufacturer Inspecs. More information is available at www.inspecsusa.com and www.zyloware.com.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.